ABSTRACT
D-Phe-D-Arg-OH 206 9 Acetyl-bradykinin Ac-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH 207 9 [Thr6 [-bradykinin H-Arg-Pro-Pro-Gly-Phe-Thr-Pro-Phe-Arg-OH 208 9 jphe6 [-bradykinin H-Arg-Pro-Pro-Gly-Phe-Phe-Pro-Phe-Arg-OH 209 9 (Lys(Tos)6 [-bradykinin H-Arg-Pro-Pro-Gly-Phe-Lys(Tos)-Pro-Phe-Arg-OH 210 9 [D-Pro2 [-bradykinin H-Arg-D-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH 211 9 [D-Pro3 [-bradykinin H-Arg-Pro-D-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH 212 9 [D-Pro7 j-bradykinin H-Arg-Pro-Pro-Gly-Phe-Ser-D-Pro-Phe-Arg-OH 213 9 Acetyl-[D-Pro7 J-bradykinin Ac-Arg-Pro-Pro-Gly-Phe-Ser-D-Pro-Phe-Arg-OH 214 9 [D-Arg9 J-bradykinin H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-D-Arg-OH 215 9 [T y r(Me) 5 ’8 [-bradykinin FI-Arg-Pro-Pro-Gly-Tyr(Me)-Ser-Pro-Tyr(Me)-
Arg-OH 216 9 Acetyl-[T yr(Me) 5 •8 J-bradykinin Ac-Arg-Pro-Pro-Gly-Tyr(Me)-Ser-Pro-Tyr(Me)-
Arg-OH 217 9 [Thr6,Leu8 J-bradykinin H-Arg-Pro-Pro-Gly-Phe-Thr-Pro-Leu-Arg-OH 218 9 |Gly6,Tyr(Me)8 [-bradykinin H-Arg-Pro-Pro-Gly-Phe-Gly-Pro-Tyr(Me)-Arg-OH 219 9 Acetyl-[Gly6,T yr(Me)8 [-bradykinin Ac-Arg-Pro-Pro-Gly-Phe-Gly-Pro-Tyr(Me)-Arg-OH 220 9 [D-Pro2 3,7 J-bradykinin H-Arg-D-Pro-D-Pro-Gly-Phe-Ser-D-Pro-Phe-Arg-OH 221 9 [Leu5 8,Thr6 J-bradykinin H-Arg-Pro-Pro-Gly-Leu-Thr-Pro-Leu-Arg-OH 222 9 [Leu5 *8,Gly6 j-bradykinin H-Arg-Pro-Pro-Gly-Leu-Gly-Pro-Leu-Arg-OH 223 9 [T yr(Me)5,8,Gly6 |-bradykinin H-Arg-Pro-Pro-Gly-Tyr(Me)-Gly-Pro-Tyr(Me)-
Arg-OH 224 9 [T yr(Me)5,8, Asn6 J-bradykinin H-Arg-Pro-Pro-Gly-Tyr(Me)-Asn-Pro-Tyr(Me)-
Arg-OH 225 9 [D-Arg1,9,D-Phe5,8,D-Ser6|-bradykinin H-D-Arg-Pro-Pro-Gly-D-Phe-D-Ser-Pro-D-Phe-
D-Arg-OH 226 9 Des-Arg1 -endo-Phe8"-bradykinin H-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Phe-Arg-OH
Entry number
Refer ence
Solid support Type of bond
Monomer protection
Coupling reagent
Deprotection Cleavage
155 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 156 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 157 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 158 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 159 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 160 S-DVB-2% Bzl Boc DCC TFA HBr-HOAc 161 S-DVB-2% Bzl Boc DCC HCr-HOAc HBr-TFA 162 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
163 S-DVB-2% Bzl Boc OSu,ONp HCl-Diox. HBr-TFA
164 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 165 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 166 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 167 S-DVB-2% Bzl Boc NEPIS HCl-HOAc HBr-TFA 168 S-DVB-2% Bzl Boc DCC,
Mixed anh. HCl-HOAc HBr-TFA
169 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 170 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
171 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 172 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 173 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 174 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc HBr-TFA 175 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 176 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 177 S-DVB-2% Bzl Boc NEPIS,
Azide HCl-Diox. HBr-TFA
178 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 179 S-DVB-2% Bzl Boc Mixed anh. TFA-CH2C12 HBr-TFA 200 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
201 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 202 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc-BME HF 203 , S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 204 S-DVB-2% Bzl Boc DCC HCl-HOAc HF 205 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
206 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 207 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 208 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 209 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 210 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 211 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 212 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 213 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 214 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 215 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
216 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
217 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 218 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 219 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 220 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 221 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 222 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 223 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
224 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
225 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
226 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
18 18 18 18 18 19 38 93
71 17 91 71 40
59 45
92 92 92 107 97 97 69
71 103 108
125 60 20 21 14 22
18 18 18 18 18 18 18 18 18 18
18 18 18 18 18 18 18
Entry number
Number of Trivial name or source Sequence residues
227 9 Des-Arg^bradykininyl-glycine H-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Gly-OH 228 9 Des-Arg'-bradykininyl-arginine H-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Arg-OH 229 9 Des-Arg1 - |Tyr(Me)5 8 )-bradykininyl-glycine H-Pro-Pro-Gly-Tyr(Me)-Ser-Pro-Tyr(Me)-Arg-
Gly-OH 230 9 D-Retrobradykinin D-Arg-D-Phe-D-Pro-D-Ser-D-Phe-Gly-D-Pro-D-Pro-
D-Arg-OH 231 9 Lysine vasopressin, protected Tos-Cys(Bzl)-Tyr-Phe-Gln-Asn-Cys(Bzl)-Pro-
LvstTosTGlv-NH i 232 9
1-/ V 1 Ujj %J j i ' i * 2 Chymotrypsin (193-201) nonapeptide H-Gly-Asp-Ser-Gly-Gly-Pro-Leu-Val-Cys(Bzl)-OH
233 9 |Tyr(Me)5,Thr6,Tyr(Me)8J-bradykinin H-Arg-Pro-Pro-Gly-Tyr(Me)-Thr-Pro-Tyr(Me)- Arg-OH
234 9 Oxytocin H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 235 9 Oxytocin H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH 2 236 9 Oxytocin H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 237 9 Oxytocin, protected H-Cys(Bzl)-Tyr-Ile-Gln-Asn-Cys(Bzl)-Pro-Leu-Gly-
n h 2 238 9 Oxytocin, protected Z-Cys(Bzl)-Tyr(Bzl)-Ile-Gln-Asn-Cys(Bzl)-Pro-
Leu-Gly-NH 239 9 Oxytocin, protected Aoc-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 240 9 Deamino-oxytocin MCP-T yr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH 2 241 9 Deamino-oxytocin, protected MCP(Bzl)-Tyr(Bzl)-Ile-Gln-Asp-Cys(Bzl)-Pro-Leu-
Gly-NH2 242 9 |Lys8|-vasopressin H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 243 9 ILys8|-vasopressin H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 244 9 JLys8|-vasopressin, protected Tos-Cys(Bzl)-Tyr-Phe-Gln-Asn-Cys(Bzl)-Pro-
Lys(Tos)-Gly-NH2 245 9 (Lys81-vasopressin, protected Z-Cys(Bzl)-Tyr(Bzl)-Phe-Gln-Asn-Cys(Bzl)-Pro-
LvsfZVGlv-NFL 246 9
y f v-i i j (Ser4,Gln8|-oxytocin H-Cys-Tyr-Ile-Ser-Asn-Cys-Pro-Gln-Gly-NH2
247 9 [Ser4,Gln8|-oxytocin, protected Z-Cys(Bzl)-Tyr(Bzl)-Ile-Ser-(Bzl)-Asn-Cys(Bzl)-ProGln-Glv-NFL
Oxytocinoic acid, protected H-Cys(Bzl)-Tyr-Ile-Gln-Asn-Cys(Bzl)-Pro-LeuGly-OH
249 9 TMV protein-<104-112) H-Thr-Ala-Glu-Thr-Leu-Asp-Ala-Thr-Arg-OH 250 9 DNP-nona lysine Dnp-Lys-Lys-Lys-Lys-D-Lys-Lys-Lys-Lys-Lys-OH 251 9 (Phe8l-oxytocin H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Phe-Gly-NH2 252 9 |Pro4,Ile8)-oxytocin H-Cys-Tyr-Ile-Pro-Asn-Pro-Ile-Gly-NH2 253 9 Oxytocinoic acid methyl ester, protected H-Cys(Bzl)-Tyr-Ile-Gln-Asn-Cys(Bzl)-Pro-Leu-
GIv-OMp 254 9
VJljf V_71V1C [Pro4,Gin81-oxytocin H-Cys-Tyr-Ile-Pro-Asn-Cys-Pro-Gln-Gly-NH2
255 9 [Pro 4,Leu8J-oxytocin H-Cys-Tyr-Ile-Pro-Asn-Cys-Pro-Leu-Gly-NH2 256 9 Mellitin-(1-9) H-Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-OH 257 9 Oxytocin methylamide, protected Z-Cys(Bzl)-Tyr-Ile-Gln-Asn-Cys(Bzl)-Pro-Leu-
Glv-NHCH, 258 9
vj i y m i 1 1 3 Oxytocin hydrazide, protected Z-Cys(Bzl)-Tyr-Ile-Gln-Asn-Cys(Bzl)-Pro-Leu-
Glv-NHNH. 259 9
Glv-NHNHOH 260 9
\j iy im il l iv / i i Ribonuclease-(1-8), protected Boc-Lys(Boc)-Glu(OBu)-Thr-Ala-Ala-Ala-Lys(Z)-
Phe-NHNH2
261 10 TMV Protein (103-112) decapeptide H-Thr-Thr-Ala-Glu-Thr-Leu-Asp-Ala-Thr-Arg-OH 262 10 Nylon 11 oligomers H-[Und]n-OH, n = 2-10 263 10 Nylon 6.6 oligomers H-[NH(CH2)6NHCO(CH2)4CO]n-OH, n = 2-10 264 10 Bradykininyl-glycine H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Gly-OH 265 10 Endo-Phe8a-bradykinin H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Phe-Arg-OH 266 10 Bradykininyl-arginine H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Arg-OH 267 10 |Ty r(Me)58 |-bradykininy 1-phenylalanine H-Arg-Pro-Pro-Gly-Tyr(Me)-Ser-Pro-Tyr(Me)-
Arff-Phe-OH 268 10
1 1 1 C"V/ 1 1 [Tyr(Me)5,8l-bradykininyl-glycine H-Arg-Pro-Pro-Gly-Tyr(Me)-Ser-Pro-Tyr(Me)-
Ara-Glv-OH 269 10
r\ i g’Vjiy-wn Gly-|Gly 6,Tyr(Me)8 ]-brady kinin H-Gly-Arg-Pro-Pro-Gly-Phe-Gly-Pro-Tyr(Me)-
Aro Ol-I 270 10
rg-un TMV protein-(103-112) H-Thr-Thr-Ala-Glu-Thr-Leu-Asp-Ala-Thr-Arg-OH
271 10 Staphylococcal nuclease-(108-117), Boc-Leu-Ala-Lys(TFA)-Val-Ala-Tyr-Val-Tyrprotected Lys(TFA)-Pro-OH
Entry number
Refer ence
Solid support Type of bond
Monomer protection
Coupling reagent
Deprotection Cleavage
227 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 228 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 229 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
230 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
231 S-DVB-2% Bzl Boc DCC HCl-HOAc N H 3
232 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 233 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
234 , S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH 3-MeOH 235 S-DVB-2% Bzl Nps DCC,ONp HCl-Diox. NH3-MeOH-DMF 236 Phenol-trioxane Phenyl Aoc DCC HCl-MeOH NH3-MeOH 237 S-DVB-2% Bzl Boc ONp,OSu-
triazole HCl-HOAc NH3-MeOH
238 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH 3-MeOH
239 Phenol-trioxane Phenyl Aoc DCC HCl-MeOH NH3-MeOH 240 N 0 2-S-DVB-2 % N 0 2Bzl Boc DCC.ONp HCl-HOAc,TFA NH3-MeOH 241 N 0 2-S-DVB-2% N 0 2Bz1 Boc DCC,ONp HCl-HOAc,TFA NH3-MeOH
242 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH3-MeOH 243 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc NH3-EtOH-DMF 244 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc N H 3-EtOH-DMF
245 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc-TFA NH 3-MeOH
246 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH3-MeOH 247 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH3-MeOH
248 S-DVB-2% Bzl Boc ONp,OSutriazole
HCl-HOAc NH3-MeOH
249 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 250 S-DVB-2% Bzl Boc,Nps DCC HCl-HOAc HBr-TFA 251 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH3-MeOH 252 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH3-MeOH 253 S-DVB-2% Bzl Boc ONp,OSu-
triazole HCl-HOAc,HC1 MeOH-A-Methyl
piperidine 254 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH3-MeOH 255 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc,TFA NH3-MeOH 256 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 257 S-DVB-2% Bzl Boc ONp,OSu-
triazole HCl-HOAc CH3NH2-MeOH
258 S-DVB-2% Bzl Boc ONp,OSutriazole
HCl-HOAc NH2NH2-MeOH
259 S-DVB-2% Bzl Boc ONp,OSutriazole
HCl-HOAc NH2NHOH-MeOH
260 S-DVB-2% Bzl Boc,Nps DCC,ONp, OPcp
HCl-HOAc,HClDiox. HClHOAc
NH2NH2-DMF
261 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 262 S-DVB-2% Bzl Boc DCC TFA HBr-HOAc 263 S-DVB-2% Bzl Boc DCC TFA HBr-HOAc 264 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 265 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 266 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 267 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
268 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
269 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
270 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 271 S-DVB-2% Bzl Boc OSu,ONp HCl-Diox. HBr-TFA
18 18 18
24 88
42 50 51 70 76
70 44 44
42 23 23
77 77
38 55 112 116 72
122 116 106 58
25 19 19 18 18 18 18
38 13
Entry number
Number of residues
Trivial name or source Sequence
272 10 |GIy5,Gly10]-gramicidin S cyclo[-Val-Orn-Leu-D-Phe-Gly-Val-Orn-Leu-DPhe-Gly-]
273 10 |Glys,Gly10]-gramacidin S cyclo[-Val-Orn-Leu-D-Phe-Gly-Val-Orn-Leu-DPhe-Gly-]
274 10 [He5]-angiotensin I H-Asp-Arg-V al-T y r-1 le-H is-Pro-Phe-H is-Leu-O H 275 10 Alanylalanylalanylalanylalanylleucylas-
partylalanythreonylarginine H-Ala-Ala-Ala-Ala-Ala-Leu-Asp-Ala-Thr-Arg-OH
276 10 Oligolysine H-(Lys)n-OH, n = 2-10 277 10 Antamanide cyclo[-Pro-Phe-Phe-Val-Pro-Pro-Ala-Phe-Phe-
Pro-] 278 11 D-Alanyl-L-alanyl-D-alanyl-L-alanyl-D-
alany 1-L-alany 1-d-alany 1-L-alany 1-DalanyI-L-alanyl-2,4 dinitropheny-L-lysine
H-D-Ala-Ala-D-Ala-Ala-D-Ala-Ala-D-Ala-AlaD-Ala-Ala-Lys(Dnp)-OH
279 11 Met-Lys-bradykinin H-Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-PheArg-OH
280 11 Casein peptide H-Val-Asp-Glu-Glu-Glu-DL-Ser-lle-Ala-MetGlu-Lys-OH
281 11 Valylserylglutamylglutamylglutamylaspartyl-H-Val-Ser-Glu-Glu-Glu-Asp-Ile-Ala-Met-Glyisoleucylalanylmethionylglutamyllysine Lys-OH
282 12 Dansyl-oligoprolyl-hydrazide Dansyl-(Pro)n-NHNH2, n = 1-12 283 12 Valinomycin cyclo-[L-Val-D-Hyv-D-Val-L-Lac] 3 284 12 Oligo(glycylprolylprolyl)glycylprolyl-
proline, labelled H-[Gly-Pro-(3,4-3H)-Pro]3-Gly-Pro-Pro-OH
285 12 01igo(glycylprolyl-3-methylprolyl)- glycylproly 1-3-methyl proline
H-[Gly-Pro-Pro(Me)]n-OH n = 1, 2, 3 and 4
286 12 OHgo(glycylprolyl-4-fluoroprolyl)- glycylprolyl-4-fluoroproline
H-[Gly-Pro-Pro(F)]n-OH n = 1, 2, 3 and 4
287 13 Nylon 6 oligomers H-[Cap]n-OH n = 2, 3, 4, 5, 7, 9, 11 and 13 288 14 Glucagon (16-29) H-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Try-
Leu-Met-Asn-Thr-OH 289 15 Cysteinylalanylvalylcysteinyl-(im-
benzyl)histidylalanylvalylalanyllysylalanylalanyl-alanylalanylalanylalanine
H-Cys-Ala-Val-Cys-His(Bzl)-Ala-Val-Ala-Lys-AlaAla-Ala-Ala-Ala-Ala-OH
290 15 Lysylalanylvalylcysteinylhistidylalanylvalylalanyllysylalanylalanylalanylalanylalanylalanine
H-Lys-Ala-Val-Cys-His-Ala-Val-Ala-Lys-Ala-AlaAla-Ala-Ala-Ala-OH
291 15 Ribonuclease-(1-15) H-Lys-Glu-Thr-Ala-Ala-Ala-Lys-Glu-Phe-Arg-GlnHis-Met-Asp-Ser-OH
292 16 T yrosylhistidy lhistidylphenylalany 1phenylalanylaspartylhistidylserylaspartylserylhistidylphenylalanylaspartylphenylalanylhistidylphenylalanine
H-Tyr-His-His-Phe-Phe-Asp-His-Ser-Asp-Ser-HisPhe-Asp-Phe-His-Phe-OH
293 16 [Ala16 [-ribonuclease-(1-16) H-Lys-Glu-Thr-Ala-Ala-Ala-Lys-Glu-Phe-Arg-GlnHis-Met-Asp-Ser-Ala-OH
294 17 Angiotensinyl-bradykinin H-Asp-Arg-Val-Tyr-lle-His-Pro-Phe-Arg-Pro-ProGly-Phe-Ser-Pro-Phe-Arg-OH
295 18 Bradykininyl-bradykinin H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-ArgPro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH
296 18 Polistes kinin PCA-Tyr-Asn-Lys-Lys-Lys-Leu-Arg-Gly-Arg-ProPro-Gly-Phe-Ser-Pro-Phe-Arg-OH
297 18 Valylserylisoleucylglutamylglutamylglutamylserylserylprolylserylvalylglutamylglutaniylglutamylaspartylserylisoleucylalanine
H-Val-Ser-Ile-Glu-Glu-Glu-Ser-Ser-Pro-Ser-Val-GluGlu-Glu-Asp-Ser-Ile-Ala-OH
298 20 Des lie2-insulin A-chain 5-sulfonate (bovine)
H-Gly-Val-Gly-Gln-Cys(S03)-Cys(S03)-Ala-SerVal-Cys(S03)-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-TyrCys(S03)-Asn-OH
299 20 Lysylaspartylglutamylglutamylglutamylglutamylvalylglutamylserylphenylalanylserylglycylprolylaspartylalanylprolylleucylprolylalanylglycine
H-Lys-Asp-Glu-Glu-Glu-Glu-Val-Glu-Ser-Phe-SerGly-Pro-Asp-Ala-Pro-Leu-Pro-Ala-Gly-OH
300 21 Insulin A-chain 5-sulfonate (bovine) H-Gly-Ile-Val-Glu-Gln-Cys(S03)-Cys(S03)-Ala-SerVal-Cys(S03)-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-TyrCys(S03)-Asn-OH
Entry number
Refer ence
Solid support Type of bond
Monomer protection
Coupling reagent
Deprotection Cleavage
272 Styrene Bzl Boc OSu HCl-Diox. HBr-HOAc
273 , S-DVB-2 % Bzl Boc DCCOSu HCl-HOAc HBr-TFA
274 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 275 S-DVB-2 % Bzl Boc DCC HCl-HOAc HBr-TFA
276 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA 277 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
278 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
279 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
280 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
281 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
282 S-DVB-2% Bzl Boc DCC HCl-HOAc NH2NH2-EtOH 283 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA 284 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
285 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
286 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
287 S-DVB-2% Bzl Boc Mixed anh. HCl-HOAc HBr-TFA 288 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc-BME HF
289 S-DVB-2% Bzl Boc DCC HCl-HOAc HF
290 S-DVB-2% Bzl Boc DCC HCl-HOAc HF
291 S-DVB-2% Bzl Boc DCC,ONp HCl-Diox. HF,HBr-TFA
292 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
293 S-DVB-2% Bzl Boc DCC,ONp HCl-Diox. HF,HBr-TFA
294 , S-DVB-1 % Bzl Boc DCC HCl-Diox. HBr-TFA
295 S-DVB-2% Bzl NPS DCC HC1 HBr-TFA
296 S-DVB-2% Bzl Boc DCCONp HCl-Diox. HBr-TFA
297 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
298 S-DVB-2% Bzl Boc ONp HCl-HOAc HBr-TFA
299 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
300 S-DVB-2% Bzl Boc DCC HCl-Diox. HBr-TFA
54 80
47 110
75 130
87 74 79
19 60
30 31
Entry Number of Trivial name or source number residues
Sequence
301 21 Insulin A-chain 5-sulfonate (bovine) H-Gly-Ile-Val-Glu-Gln-Cys(S03)-Cys(S03)-AlaSer-Val-Cys(S03)-Ser-Leu-Tyr-G!n-Leu-Glu-AsnTyr-Cys(S03)-Asn-OH
302 21 Insulin A-chain 5-sulfonate (sheep) H-Glu-Ile-Val-Glu-Gln-Cys(S03)-Cys(S03)-AlaGly-Val-Cys(S03)-Ser-Leu-Tyr-Gln-Leu-Glu-AsnTyr-Cys(S03)-Asn-OH
H-Gly-Ile-Val-Glu-Gln-Cys(S03)-Cys(S03)-AlaGly-Val-Cys(S03)-Ala-Leu-Ala-Gln-Leu-Glu-AsnTyr-Cys(S03)-Asn-OH
304 21 [Ala^-insulin A-chain 5-sulfonate (bovine) H-Ala-Ile-Val-Glu-Gln-Cys(S03)-Cys(S03)-AlaSer-Val-Cys(S03)-Ser-Leu-Tyr-Gln-Leu-Glu-AsnTyr-Cys(S03)-Asn-OH
305 21 [Ala7,Ala20]-insulin A-chain (bovine) H-Gly-Ile-Val-Glu-Gln-Cys-Ala-Ala-Ser-Val-CysSer-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Ala-Asn-OH
306 21 Insulin A-chain 5-sulfonate (human) H-Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-IleCys(S03)-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-TyrCys(S03)-Asn-OH
307 21 [Val2 [-insulin A-chain 5-sulfonate (sheep) H-Gly-Val-Val-Glu-Gln-Cys(S03)-Cys(S03)-Ala-GlyVal-Cys(S03)-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-TyrCys(S03)-Asn-OH
H-Gly-Ile-Val-Glu-Glu-Cys(S03)-Cys(S03)-AlaGly-Val-Cys(S03)-Ala-Leu-Ala-Glu-Leu-Glu-AlaPhe-Cys(S03)-Ala-OH
H-Gly-Val-Val-Glu-Glu-Cys(S03)-Cys(S03)-AlaGly-Val-Cys(S03)-Ala-Leu-Ala-Glu-Leu-Glu-AlaPhe-Cys(S03)-Ala-OH
310 21 [Leu2 [-insulin A-chain 5-sulfonate (sheep) H-Gly-Leu-Val-Glu-Gln-Cys(S03)-Ala-Gly-ValCys(S03)-Ser-Leu-Tyr-Gln-Leu-Gln-Asn-TyrCys(S03)-Asn-OH
H-Gly-Ile-Val-Glu-Gln-Ala-Cys(S03)-Ala-GlyVal-Ala-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-TyrCys(S03)-Asn-OH
312 23 Hemoglobin B-chain (124-146) (human) H-Pro-Pro-Val-Gln-Ala-Ala-Tyr-Gln-Lys-Val-ValAla-Gly-Val-Ala-Asn-Ala-Leu-Ala-His-Lys-TyrHis-OH
313 25 Oligoaminocaproic acid amide H[NH(CH2)5CO]n-OH n = 3,5,7,9,11,13,15,17,21,25 314 27 Oligolysyl-decaalanyl-oligolysylglycine H-[Lys]n-[Ala]10-[Lys]n-Gly-OH n = 7.9 315 28 [des-Phe1 ,des-Val2,Ala 4[-insulin B-chain
5-sulfonate (bovine) H-Asn-Ala-His-Leu-Cys(S03)-Gly-Ser-His-LeuVal-Glu-Ala-Leu-Tyr-Leu-Val-Cys(S03)-GlyGlu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala-OH
H-Val-Asn-Gln-His-Leu-Cys(S03)-Gly-Ser-HisLeu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys(S03)- Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-LysAla-OH
317 30 Insulin B-chain 5-sulfonate (bovine) H-Phe-Val-Asn-Gln-His-Leu-Cys(S03)-Gly-SerHis-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys(S03)- Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-LysAla-OH
318 30 Insulin B-chain 5-sulfonate (human) H-Phe-Va!-Asn-Gln-His-Leu-Cys(S03)-Gly-SerHis-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys(S03)- Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-LysAla-OH
319 30 |Ala3 [-insulin B-chain 5-sulfonate (bovine) H-Phe-Val-Ala-Gln-His-Leu-Cys(S03)-Gly-SerHis-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys(S03)- Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-LysAla-OH
320 30 [Ala4|-insulin B-chain 5-sulfonate (bovine) H-Phe-Val-Asn-Ala-His-Leu-Cys(S03)-Gly-SerHis-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys(S03)- Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-AlaOH
321 30 [Ala9 [-insulin B-chain 5-sulfonate (bovine) H-Phe-Val-Asn-Gln-His-Leu-Cys(S03)-Gly-AlaHis-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys(S03)- Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-LysAla-OH
Entry number
Refer ence
Solid support Type of bond
Monomer protection
Coupling reagent
Deprotection Cleavage
301 S-DVB-2% Bzl Boc ONp HCl-Diox. HBr-TFA
302 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc HBr-TFA
303 S-DVB-2% Bzl Boc ONp HCl-HOAc HBr-TFA
304 S-DVB-2% Bzl Boc ONp HCl-HOAc HBr-TFA
305 S-DVB-2% Bzl Boc DCC,ONp HCl-Diox. HBr-TFA
306 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc HBr-TFA
307 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc HBr-TFA
308 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
309 S-DVB-2% Bzl Boc DCC HCl-HOAc HBr-TFA
310 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc HBr-TFA
311 S-DVB-2% Bzl Boc ONp HCl-HOAc HBr-TFA
312 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc HBr-TFA
313 , S-DVB-2% Bzl Boc Mixed anh. HCl-HOAc HBr-TFA 314 S-DVB-2% Bzl Boc NCA,DCC HCl-HOAc HBr-TFA 315 S-DVB-1 % Bzl Boc DCC,ONp HCl-Diox. HBr-TFA
316 S-DVB-1 % Bzl Boc DCC,ONp HCl-Diox. HBr-TFA
317 S-DVB-2% Bzl Boc DCC,Np HCl-HOAc HBr-TFA
318 S-DVB-2% Bzl Boc DCC,ONp HCl-HOAc HBr-TFA
319 S-DVB-1 % Bzl Boc DCC,ONp HCl-Diox. HBr-TFA
320 S-DVB-1 % Bzl Boc DCC,ONp HCl-Diox. HBr-TFA
321 S-DVB-1 % Bzl Boc DCC,ONp HCl-Diox. HBr-TFA
28 102 131 81
33, 34
35, 84
Entry number
Number of residues
Trivial name or source Sequence
322 42 Staphylococcal nuclease (6-47) H-Lys-Leu-His-Lys-Glu-Pro-Ala-Thr-Leu-lleLys-Ala-Ile-Asp-Gly-Asp-Thr-Val-Lys-LeuMet-Tyr-Lys-Gly-Gln-Pro-Met-Thr-Phe-Arg-LeuLeu-Leu-Val-Asp-Thr-Pro-Glu-Thr-Lys-HisPro-OH
323 50 Oligolysyl-oligovalyl-oligolysylglycine (DL-Lys) 1 8-( Val) 15-(DL-Lys) 16-Gly-OH 324 55 Apoferrodoxin 5-sulfonate
C. pasteurianum H-Ala-Tyr-Lys-Ile-Ala-Asp-Ser-Cys(S03)-ValSer-Cys(S03)-Gly-Ala-Cys(S03)-Ala-Ser-GluCys(S03)-Pro-Val-Asn-Ala-Ile-Ser-Gln-Gly-AspSer-lle-Phe-Val-Ile-Asp-Ala-Asp-ThrCys(S03)-!le-Asp-Cys(S03)-Gly-Asn-Cys(S03)-AlaAsn-Val-Cys(S03)-Pro-Val-Gly-Ala-Pro-ValGln-Glu-OH
325 55 Polylysyloligoalanylglycine H(DL-Lys)3 o-(Ala-d4)24-G ly-d2-OH 326 60 Poly(prolylprolylglycyl)prolylprolylglycine H-(Pro-Pro-Gly)20OH 327 104 [His(Bzl)26’33, Phe59]-apocytochrome c
horse heart Ac-Gly-Asp-Val-Glu-Lys-Gly-Lys-Lys-Ile-
Phe-Val-Gln-Lys-Cys-Ala-Glu-Cys-His-ThrVal-Glu-Lys-Gly-Gly-Lys-His-Lys-Thr-GlyPro-Asn-Leu-His-Gly-Leu-Phe-Gly-Arg-LysThr-Gly-Gln-Ala-Pro-Gly-Phe-Thr-Tyr-Thr-AspAla-Asn-Lys-Asn-Lys-Gly-Ile-Thr-Trp-Lys-Glu-GluThr-Leu-Met-Glu-Tyr-Leu-Glu-Asn-Pro-Lys-LysTyr-lle-Pro-Gly-Thr-Lys-Met-lle-Phe-AlaGly-Ile-Lys-Lys-Lys-Thr-Glu-Arg-Glu-AspLeu-Ile-Ala-Tyr-Leu-Lys-Lys-Ala-ThrAsn-Glu-OH
328 124 Pancreatic Ribonuclease A 5-sulfonate (bovine)
H-Lys-Glu-Thr-Ala-Ala-Ala-Lys-Phe-Glu-ArgGln-His-Met-Asp-Ser-Ser-Thr-Ser-Ala-Ala-SerSer-Ser-Asn-Tyr-Cys(S03)-Asn-Gln-MetMet-Lys-Ser-Arg-Asn-Leu-Thr-Lys-Asp-ArgCys(S03)-Lys-Pro-Val-Asn-Thr-Phe-Val-HisGlu-Ser-Leu-Ala-Asp-Val-Gln-Ala-Val-Cys(S03)- Ser-Gln-Lys-Asn-Val-Ala-Cys(S03)-Lys-AsnGly-Gln-Thr-Asn-Cys(S03)-Tyr-Gln-Ser-TyrSer-Thr-Met-Ser-!le-Thr-Asp-Cys(S03)-ArgGlu-Thr-Gly-Ser-Ser-Lys-Tyr-Pro-Asn-Cys(S03)- Ala-Tyr-Lys-Thr-Thr-Gln-Ala-Asn-Lys-His-IleIle-Val-Ala-Cys(S03)-Glu-Gly-Asn-Pro-TyrVal-Pro-Val-His-Phe-Asp-Ala-Ser-Val-OH
Entry number
Refer ence
Solid support Type of Monomer Coupling Deprotection Cleavage bond protection reagent
322 S-DVB-2% Bzl Boc DCC,ONp HCl-Diox. HF
323 S-DVB-2% Bzl Boc NCA,DCC HCl-HOAc HBr-TFA 324 S-DVB-2% Bzl Boc DCC.ONp HCl-HOAc HBr-TFA
325 S-DVB-2% Bzl Boc OSu HCl-HOAc HBr-TFA 326 S-DVB-2% Bzl Aoc DCC HCl-HOAc HF 327 S-DVB-2% Bzl Boc DCC,ONp, HCl-Diox. HF
OSu
328 S-DVB-1 % Bzl Boc DCC,ONp TFA-CH2C12 HF
Compiled by G. R. Marshall and R. B. Merrifield.
